Details
Stereochemistry | EPIMERIC |
Molecular Formula | C16H21NO3 |
Molecular Weight | 275.3434 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 2 / 3 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CN1[C@@]2([H])CC[C@]1([H])C[C@@]([H])(C2)OC(=O)C([H])(c3ccccc3)O
InChI
InChIKey=ZTVIKZXZYLEVOL-MCOXGKPRSA-N
InChI=1S/C16H21NO3/c1-17-12-7-8-13(17)10-14(9-12)20-16(19)15(18)11-5-3-2-4-6-11/h2-6,12-15,18H,7-10H2,1H3/t12-,13+,14+,15?
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL2094109 |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Palliative | HYDROCODONE BITARTRATE AND HOMATROPINE METHYLBROMIDE Approved UseHydrocodone bitartrate and homatropine methylbromide syrup is indicated for the symptomatic relief of cough. Launch Date4.15497585E11 |
PubMed
Title | Date | PubMed |
---|---|---|
Anticholinergic delirium caused by topical homatropine ophthalmologic solution: confirmation by anticholinergic radioreceptor assay in two cases. | 1992 Spring |
|
Buspirone, but not sumatriptan, induces miosis in humans: relevance for a serotoninergic pupil control. | 1995 Mar |
|
Herpes simplex virus type 1 associated acute retinal necrosis following encephalitis. | 2001 |
|
Tris(2,2'-bipyridine)ruthenium(II) electrogenerated chemiluminescence of alkaloid type drugs with solid phase extraction sample preparation. | 2001 Jan |
|
[Neurological manifestations in the intoxication of infants by dimethicone combined with homatropine: report of 6 cases]. | 2001 Jun |
|
Contact allergy to atropine and other mydriatic agents in eye drops. | 2001 Nov |
|
Scavenging of photogenerated oxidative species by antimuscarinic drugs: atropine and derivatives. | 2002 |
|
[Effect of pilocarpine and cycloplegic substances on ophthalmic tone in healthy eyes and ones with glaucoma]. | 2002 Jan-Feb |
|
Topical ketorolac tromethamine 0.5% versus diclofenac sodium 0.1% to inhibit miosis during cataract surgery. | 2002 Mar |
|
Bilateral panuveitis in a child with hypohidrotic ectodermal dysplasia. | 2002 Sep |
|
Human carboxylesterase 1: from drug metabolism to drug discovery. | 2003 Jun |
|
Structural basis of heroin and cocaine metabolism by a promiscuous human drug-processing enzyme. | 2003 May |
|
Corneal topographic changes following retinal surgery. | 2004 Aug 3 |
|
Dense membrane formation after combined phacoemulsification-trabeculectomy surgery. | 2005 Jun |
|
Evaluation of amniotic membrane transplantation as an adjunct to medical therapy as compared with medical therapy alone in acute ocular burns. | 2005 Nov |
|
Homatropine and psychosis in Weill-Marchesani syndrome. | 2006 Jul |
|
Role of the medial prefrontal cortex in cardiovascular responses to acute restraint in rats. | 2006 Nov 17 |
|
Enantioseparation of chiral tropa alkaloids by means of cyclodextrin-modified microemulsion electrokinetic chromatography. | 2007 Aug |
|
Acute retinal necrosis complicating chickenpox in a healthy adult--a case report and review of literature. | 2007 Spring |
|
Voriconazole for the treatment of refractory Aspergillus fumigatus keratitis. | 2008 May-Jun |
|
First aid for complications of infectious keratitis. | 2008 May-Jun |
|
Managing corneal disease: focus on suppurative keratitis. | 2009 Dec |
|
Syphilitic palmoplantar keratoderma and ocular disease: a rare combination in an HIV-positive patient. | 2009 Dec |
|
Peripheral ulcerative keratitis with bilateral optic nerve involvement as an initial presentation of acute lymphocytic leukemia in an adult. | 2009 Feb |
|
Adverse drug effects in hospitalized elderly: data from the healthcare cost and utilization project. | 2010 |
|
Tubulointerstitial nephritis with uveitis syndrome: A case report and review of literature. | 2010 Apr |
|
Is homatropine 5% effective in reducing pain associated with corneal abrasion when compared with placebo? A randomized controlled trial. | 2010 Dec |
|
Acute postoperative endophthalmitis by Gemella haemolysans. | 2010 May-Jun |
|
Refractive error and visual functions in children with special needs compared with the first grade school students in oman. | 2010 Oct |
|
Homocysteinethiolactone and paraoxonase: novel markers of diabetic retinopathy. | 2010 Sep |
|
Profiling of a prescription drug library for potential renal drug-drug interactions mediated by the organic cation transporter 2. | 2011 Jul 14 |
|
Efficacy assessment of various anticholinergic agents against topical sarin-induced miosis and visual impairment in rats. | 2012 Apr |
Sample Use Guides
Adults and Adolescents 12 Years of Age and Older: 1 tablet or 5 mL (1 teaspoonful) of the oral solution every 4 to 6 hours as needed; do not exceed 6 tablets or 30 mL (6 teaspoonfuls) in 24 hours. Children 6 to 11 Years of Age: 1/2 tablet or 2.5 mL (1/2 teaspoonful) of the oral solution every 4 to 6 hours as needed; do not exceed 3 tablets or 15 mL (3 teaspoonfuls) in 24 hours.
Route of Administration:
Oral
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/20085574
Isolated caprine urinary bladder detrusor muscle strips were incubated with homatropine at 5 uM after being contracted with 100 mum acetylcholine. The drug inhibited the ACh-induced contraction of the caprine detrusor and that this inhibition was reversed by raising the concentration of ACh.
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NDF-RT |
N0000000104
Created by
admin on Fri Jun 25 22:30:11 UTC 2021 , Edited by admin on Fri Jun 25 22:30:11 UTC 2021
|
||
|
NDF-RT |
N0000000104
Created by
admin on Fri Jun 25 22:30:11 UTC 2021 , Edited by admin on Fri Jun 25 22:30:11 UTC 2021
|
||
|
WHO-VATC |
QS01FA05
Created by
admin on Fri Jun 25 22:30:11 UTC 2021 , Edited by admin on Fri Jun 25 22:30:11 UTC 2021
|
||
|
NDF-RT |
N0000175840
Created by
admin on Fri Jun 25 22:30:11 UTC 2021 , Edited by admin on Fri Jun 25 22:30:11 UTC 2021
|
||
|
NDF-RT |
N0000000104
Created by
admin on Fri Jun 25 22:30:11 UTC 2021 , Edited by admin on Fri Jun 25 22:30:11 UTC 2021
|
||
|
NCI_THESAURUS |
C29704
Created by
admin on Fri Jun 25 22:30:11 UTC 2021 , Edited by admin on Fri Jun 25 22:30:11 UTC 2021
|
||
|
WHO-ATC |
S01FA05
Created by
admin on Fri Jun 25 22:30:11 UTC 2021 , Edited by admin on Fri Jun 25 22:30:11 UTC 2021
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
DB11181
Created by
admin on Fri Jun 25 22:30:11 UTC 2021 , Edited by admin on Fri Jun 25 22:30:11 UTC 2021
|
PRIMARY | |||
|
Homatropine
Created by
admin on Fri Jun 25 22:30:11 UTC 2021 , Edited by admin on Fri Jun 25 22:30:11 UTC 2021
|
PRIMARY | |||
|
1379
Created by
admin on Fri Jun 25 22:30:11 UTC 2021 , Edited by admin on Fri Jun 25 22:30:11 UTC 2021
|
PRIMARY | |||
|
M6038
Created by
admin on Fri Jun 25 22:30:11 UTC 2021 , Edited by admin on Fri Jun 25 22:30:11 UTC 2021
|
PRIMARY | Merck Index | ||
|
201-716-8
Created by
admin on Fri Jun 25 22:30:11 UTC 2021 , Edited by admin on Fri Jun 25 22:30:11 UTC 2021
|
PRIMARY | |||
|
CHEMBL1618018
Created by
admin on Fri Jun 25 22:30:11 UTC 2021 , Edited by admin on Fri Jun 25 22:30:11 UTC 2021
|
PRIMARY | |||
|
8QS6WCL55Z
Created by
admin on Fri Jun 25 22:30:11 UTC 2021 , Edited by admin on Fri Jun 25 22:30:11 UTC 2021
|
PRIMARY | |||
|
87-00-3
Created by
admin on Fri Jun 25 22:30:11 UTC 2021 , Edited by admin on Fri Jun 25 22:30:11 UTC 2021
|
PRIMARY | |||
|
C100236
Created by
admin on Fri Jun 25 22:30:11 UTC 2021 , Edited by admin on Fri Jun 25 22:30:11 UTC 2021
|
PRIMARY | |||
|
HOMATROPINE
Created by
admin on Fri Jun 25 22:30:11 UTC 2021 , Edited by admin on Fri Jun 25 22:30:11 UTC 2021
|
PRIMARY | |||
|
27084
Created by
admin on Fri Jun 25 22:30:11 UTC 2021 , Edited by admin on Fri Jun 25 22:30:11 UTC 2021
|
PRIMARY | RxNorm | ||
|
SUB02529MIG
Created by
admin on Fri Jun 25 22:30:11 UTC 2021 , Edited by admin on Fri Jun 25 22:30:11 UTC 2021
|
PRIMARY | |||
|
87-00-3
Created by
admin on Fri Jun 25 22:30:11 UTC 2021 , Edited by admin on Fri Jun 25 22:30:11 UTC 2021
|
PRIMARY | |||
|
C61783
Created by
admin on Fri Jun 25 22:30:11 UTC 2021 , Edited by admin on Fri Jun 25 22:30:11 UTC 2021
|
PRIMARY |
ACTIVE MOIETY
SALT/SOLVATE (PARENT)
SALT/SOLVATE (PARENT)
SALT/SOLVATE (PARENT)